PATENT
Patented Collusion Detection Technology Transforming Healthcare Payment Integrity
4L Data Intelligence™ has strengthened its intellectual property portfolio with the issuance of U.S. Patent Number 12,184,508 B2 for "Detection of Operational Threats Using Artificial Intelligence." This continuation patent specifically focuses on provider collusion detection capabilities within the company's Integr8 AI Risk Detection™ technology
The newly secured patent reinforces 4L Data Intelligence™’s position as the leader in provider-centric approaches to healthcare fraud, waste, and abuse (FWA) prevention. While traditional payment integrity solutions rely solely on claims data-centric analysis, 4L’s patented technology monitors provider behaviors, relationships, and integrity issues in near real-time.
This patent is part of a strategic portfolio targeting the detection and prevention of complex FWA schemes in healthcare, as reported by AP News and California Health Watch.
“Our latest patent further validates our unique provider-centric approach to healthcare payment integrity,” said Clay Wilemon, CEO of 4L Data Intelligence™. “This technology enables us to detect collusion schemes that traditional systems simply cannot see, helping our customers prevent significant losses before they occur.”
The patented technology is already delivering measurable results for healthcare payers nationwide. As highlighted in coverage by KDVR and 247 Business Reporter, the company’s provider-centric methodology has demonstrated the ability to reduce total claims costs by 5-15% compared to traditional approaches.
With this patent, 4L Data Intelligence™ continues to advance its Find, Fight & Prevent FWA Fast™ mission, giving healthcare payers the technology they need to detect what others miss across the entire claims workflow.
